Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: glycoconjugate vaccines - LimmaTech Biologics

Drug Profile

Research programme: glycoconjugate vaccines - LimmaTech Biologics

Alternative Names: Staphylococcus aureus vaccine - GlycoVaxyn; Glycoconjugate vaccines - GlycoVaxyn; Group A Streptococcus conjugate vaccine - GlycoVaxyn; Group B meningococcal vaccine - GlycoVaxyn; Uropathogenic E.Coli vaccine - GlycoVaxyn

Latest Information Update: 28 Aug 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlycoVaxyn
  • Developer LimmaTech Biologics
  • Class Bacterial vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Bacterial infections; Staphylococcal infections

Most Recent Events

  • 28 Aug 2018 No recent reports of development identified for preclinical development in Bacterial-infections in Switzerland (Parenteral)
  • 28 Aug 2018 No recent reports of development identified for preclinical development in Staphylococcal-infections in Switzerland (Parenteral)
  • 28 Aug 2018 No recent reports of development identified for preclinical development in Staphylococcal-infections in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top